Clinical trials
Recruiting Observational Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 8 |
| 2022 | 11 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 11 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 78 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 9 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 3 |
| St. Jude Children's Research Hospital | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Center for International Blood and Marrow Transplant Research | 2 |
| Dana-Farber Cancer Institute | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Mayo Clinic | 2 |
| Munich Leukemia Laboratory | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 78 |
| Neoplasms | 13 |
| Leukemia | 11 |
| Lymphoma | 10 |
| Leukemia, Myeloid, Acute | 8 |
| Breast Neoplasms | 6 |
| Multiple Myeloma | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
| Lung Neoplasms | 5 |
Trials
Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.